| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| MousePheno | abnormal pectoral girdle bone morphology | 9.20e-06 | 301 | 24 | 6 | MP:0004508 | |
| MousePheno | abnormal hindlimb morphology | 3.65e-05 | 576 | 24 | 7 | MP:0000556 | |
| MousePheno | abnormal sternum morphology | 6.21e-05 | 255 | 24 | 5 | MP:0000157 | |
| MousePheno | abnormal appendicular skeleton morphology | 8.07e-05 | 896 | 24 | 8 | MP:0009250 | |
| MousePheno | abnormal fibula morphology | 8.77e-05 | 51 | 24 | 3 | MP:0002187 | |
| MousePheno | abnormal thoracic cage morphology | 1.03e-04 | 463 | 24 | 6 | MP:0004624 | |
| MousePheno | abnormal forelimb morphology | 2.41e-04 | 182 | 24 | 4 | MP:0000550 | |
| MousePheno | abnormal limb long bone morphology | 3.15e-04 | 568 | 24 | 6 | MP:0011504 | |
| MousePheno | abnormal limb bone morphology | 3.76e-04 | 587 | 24 | 6 | MP:0002115 | |
| MousePheno | abnormal tibia morphology | 3.77e-04 | 375 | 24 | 5 | MP:0000558 | |
| MousePheno | abnormal hindlimb zeugopod morphology | 4.06e-04 | 381 | 24 | 5 | MP:0003857 | |
| MousePheno | double outlet right ventricle with atrioventricular septal defect | 5.27e-04 | 20 | 24 | 2 | MP:0011667 | |
| Domain | Growth_fac_rcpt_ | 6.40e-06 | 156 | 32 | 5 | IPR009030 | |
| Domain | PLAC | 2.55e-04 | 14 | 32 | 2 | PF08686 | |
| Domain | PI3_4_KINASE_1 | 4.28e-04 | 18 | 32 | 2 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 4.28e-04 | 18 | 32 | 2 | PS00916 | |
| Domain | PI3/4_kinase_cat_dom | 4.28e-04 | 18 | 32 | 2 | IPR000403 | |
| Domain | PI3_PI4_kinase | 4.28e-04 | 18 | 32 | 2 | PF00454 | |
| Domain | PI3_4_KINASE_3 | 4.28e-04 | 18 | 32 | 2 | PS50290 | |
| Domain | PLAC | 4.78e-04 | 19 | 32 | 2 | IPR010909 | |
| Domain | PLAC | 4.78e-04 | 19 | 32 | 2 | PS50900 | |
| Domain | EGF_Ca-bd_CS | 6.04e-04 | 97 | 32 | 3 | IPR018097 | |
| Domain | EGF_CA | 6.41e-04 | 99 | 32 | 3 | PS01187 | |
| Domain | ASX_HYDROXYL | 6.60e-04 | 100 | 32 | 3 | PS00010 | |
| Domain | EGF | 6.66e-04 | 235 | 32 | 4 | SM00181 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 7.82e-04 | 106 | 32 | 3 | IPR000152 | |
| Domain | EGF-like_dom | 8.27e-04 | 249 | 32 | 4 | IPR000742 | |
| Domain | EGF_CA | 1.17e-03 | 122 | 32 | 3 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.23e-03 | 124 | 32 | 3 | IPR001881 | |
| Domain | LAM_G_DOMAIN | 1.92e-03 | 38 | 32 | 2 | PS50025 | |
| Domain | Laminin_G_2 | 2.13e-03 | 40 | 32 | 2 | PF02210 | |
| Domain | LamG | 2.57e-03 | 44 | 32 | 2 | SM00282 | |
| Domain | Laminin_G | 4.43e-03 | 58 | 32 | 2 | IPR001791 | |
| Domain | TSP_1 | 5.20e-03 | 63 | 32 | 2 | PF00090 | |
| Domain | Zinc_finger_PHD-type_CS | 5.53e-03 | 65 | 32 | 2 | IPR019786 | |
| Domain | TSP1 | 5.53e-03 | 65 | 32 | 2 | SM00209 | |
| Domain | TSP1_rpt | 5.53e-03 | 65 | 32 | 2 | IPR000884 | |
| Domain | TSP1 | 5.53e-03 | 65 | 32 | 2 | PS50092 | |
| Domain | EGF_3 | 7.45e-03 | 235 | 32 | 3 | PS50026 | |
| Domain | Znf_RING/FYVE/PHD | 7.51e-03 | 459 | 32 | 4 | IPR013083 | |
| Domain | C_TYPE_LECTIN_1 | 8.27e-03 | 80 | 32 | 2 | PS00615 | |
| Domain | Lectin_C | 9.08e-03 | 84 | 32 | 2 | PF00059 | |
| Domain | CLECT | 9.08e-03 | 84 | 32 | 2 | SM00034 | |
| Domain | C_TYPE_LECTIN_2 | 9.29e-03 | 85 | 32 | 2 | PS50041 | |
| Domain | EGF_1 | 9.32e-03 | 255 | 32 | 3 | PS00022 | |
| Domain | C-type_lectin-like | 9.50e-03 | 86 | 32 | 2 | IPR001304 | |
| Domain | EGF_CA | 9.50e-03 | 86 | 32 | 2 | PF07645 | |
| Domain | EGF-like_CS | 9.92e-03 | 261 | 32 | 3 | IPR013032 | |
| Domain | EGF_2 | 1.03e-02 | 265 | 32 | 3 | PS01186 | |
| Domain | - | 1.15e-02 | 95 | 32 | 2 | 2.60.120.200 | |
| Domain | C-type_lectin-like/link | 1.24e-02 | 99 | 32 | 2 | IPR016186 | |
| Domain | ZF_RING_1 | 1.33e-02 | 291 | 32 | 3 | PS00518 | |
| Domain | ZF_RING_2 | 1.42e-02 | 298 | 32 | 3 | PS50089 | |
| Domain | CTDL_fold | 1.44e-02 | 107 | 32 | 2 | IPR016187 | |
| Pubmed | 5.84e-06 | 38 | 32 | 3 | 28218735 | ||
| Pubmed | 8.46e-06 | 306 | 32 | 5 | 18973680 | ||
| Pubmed | 1.72e-05 | 7 | 32 | 2 | 11528125 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 5.38e-05 | 1105 | 32 | 7 | 35748872 | |
| Pubmed | 1.54e-04 | 20 | 32 | 2 | 11707078 | ||
| Pubmed | Mutations of the Transcriptional Corepressor ZMYM2 Cause Syndromic Urinary Tract Malformations. | 2.08e-04 | 125 | 32 | 3 | 32891193 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | 2.90e-04 | 1016 | 32 | 6 | 19056867 | |
| Pubmed | 3.28e-04 | 29 | 32 | 2 | 33527355 | ||
| Pubmed | 4.00e-04 | 32 | 32 | 2 | 27292642 | ||
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | 4.72e-04 | 719 | 32 | 5 | 35337019 | |
| Pubmed | 4.77e-04 | 1116 | 32 | 6 | 31753913 | ||
| Pubmed | 4.79e-04 | 35 | 32 | 2 | 23291589 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 6.59e-04 | 774 | 32 | 5 | 15302935 | |
| Cytoband | 21q22.3 | 3.62e-03 | 128 | 32 | 2 | 21q22.3 | |
| ToppCell | IIH-CD4-CD8_2|IIH / Condition, Cell_class and T cell subcluster | 2.77e-06 | 137 | 32 | 4 | 5614a086f5f698e0965f3c7699cffefec5c3b87e | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-6_VIP_PENK|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.36e-06 | 169 | 32 | 4 | eb3b8e473192c4b8688f2f8da400116dd6fe193d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.81e-06 | 178 | 32 | 4 | 31c847d7f7aa0f6d820afbb45d507992f5e9dc2f | |
| ToppCell | 367C-Endothelial_cells-Endothelial-B_(Artery)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 9.09e-06 | 185 | 32 | 4 | b57dae20c21f984edd2acee4344d86f033108ebf | |
| ToppCell | 367C-Endothelial_cells-Endothelial-B_(Artery)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 9.09e-06 | 185 | 32 | 4 | d3b054d203e575c1bb5455aa7a2e551a0957a760 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-PENK-L1-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.24e-05 | 200 | 32 | 4 | 08a00b0687bef5fef12bfa8e52ae4570071bae5e | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-PENK|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.24e-05 | 200 | 32 | 4 | 266990ee2e835e98b92dfdf7e3114f9737ffa85e | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_ALM_Olfr111_Nxph1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.11e-05 | 122 | 32 | 3 | dba1c647172a11381efcb178a23808161908daa3 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_VISp_Col8a1_Rxfp1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.12e-04 | 131 | 32 | 3 | 81efe8b0ca4377e557a42ddb12aecaf3f46b15bf | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_P2ry12|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.12e-04 | 131 | 32 | 3 | 80630812f8894b9358d36dc2dd03fea7ee870502 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-6_VIP_PENK|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.74e-04 | 152 | 32 | 3 | 88a810d41edb5a917c23cb5ba5a387227e1312cb | |
| ToppCell | facs-Lung-18m-Hematologic-Lymphocytic_NK_ILC|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.10e-04 | 162 | 32 | 3 | 04ccd3d216f8f41afd3434a61264f03d6324db35 | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_T_CD4-Tfh|GI_large-bowel / Manually curated celltypes from each tissue | 2.14e-04 | 163 | 32 | 3 | 4104d3b9748b39cb0744c9be76db21bdda566a0d | |
| ToppCell | facs-Lung-EPCAM-24m-Lymphocytic-Ly6g5b+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.18e-04 | 164 | 32 | 3 | 4e1861382c9e93856da19303474c8975c19706d2 | |
| ToppCell | facs-Lung-EPCAM-24m-Lymphocytic-T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.18e-04 | 164 | 32 | 3 | 467ad12884b70d243988174ae960ee2b7b6cfb0c | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-immature_innate_lymphoid_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.30e-04 | 167 | 32 | 3 | 5d1919bea8e5a52ac6fc953caff15509b7142923 | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-immature_innate_lymphoid_cell-Ly6g5b+_T|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.30e-04 | 167 | 32 | 3 | d8f497860d48342a3aaaad328f88e4d55ab4faeb | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-5_VIP_KCNJ2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.38e-04 | 169 | 32 | 3 | d161dd8eb22633392b6c6466ee9eff4042464149 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.43e-04 | 170 | 32 | 3 | 417b77c12a7982b1ce4b4bc57f30335d261220f5 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.47e-04 | 171 | 32 | 3 | 52fdc2a4ec36fb91583b1215362548ceb6740ae1 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.47e-04 | 171 | 32 | 3 | ea60d9e9df28ab991fbdb596784b44f6a9fc5827 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.47e-04 | 171 | 32 | 3 | e3cab55f39879e2bd3e8bda91802181075839bc4 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-5_VIP_KCNJ2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.60e-04 | 174 | 32 | 3 | fdadac1eaab2c4a67e4832f0901df22e893add6a | |
| ToppCell | COVID-19-kidney-Podocyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.64e-04 | 175 | 32 | 3 | a73e3a65fd5c1e09cb0c2dae20c1a7bfcae49223 | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell-CD4-positive,_alpha-beta_T_cell_l21|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.64e-04 | 175 | 32 | 3 | e7b0eda141b638f1aad9938aaa76b1ce80171be9 | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-CD4+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-04 | 178 | 32 | 3 | 8fab75295780e18ee7b4556d66b641c20de10dd2 | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-04 | 178 | 32 | 3 | 730720598c530d2a413ef2a3354ecc66ebb4698c | |
| ToppCell | Control-Epithelial-Basal|Control / Disease state, Lineage and Cell class | 2.96e-04 | 182 | 32 | 3 | caddd0a52f0234ea6a916186ffaf2454cdcd80ee | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.96e-04 | 182 | 32 | 3 | 420a8fd30543e37a66ba0786215d056d308660d0 | |
| ToppCell | COVID-19_Convalescent-Lymphoid_T/NK-CD8+_T_naive|COVID-19_Convalescent / Disease group, lineage and cell class | 3.06e-04 | 184 | 32 | 3 | 0299cd30a3ea8e861a9d529043c204048ae21d29 | |
| ToppCell | remission-CD8+_T_naive|remission / disease stage, cell group and cell class | 3.06e-04 | 184 | 32 | 3 | fe20fa4457d4a4a75689978275b0afb5f6243faf | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.06e-04 | 184 | 32 | 3 | f506d0ee48f39d6f59f19554217dfdf0987cc405 | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.06e-04 | 184 | 32 | 3 | 8bcb1c4bc8ffef74338cdade926a94711de93c64 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.11e-04 | 185 | 32 | 3 | 863a3d44c1f115942d7a2a2b63a92fe5fc768814 | |
| ToppCell | COVID-19_Convalescent-CD8+_T_naive|COVID-19_Convalescent / Disease condition and Cell class | 3.11e-04 | 185 | 32 | 3 | 2f8277a0b58fb0c49fa76ff6dfa6da961da1f9f5 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.11e-04 | 185 | 32 | 3 | e64e8c98dd88d91f6501d3fb10b60fd2f3c90af3 | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_C|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 3.11e-04 | 185 | 32 | 3 | 427176ad9ab8d9511200fb0a132cfd1e835fe35c | |
| ToppCell | remission-CD8+_T_naive|World / disease stage, cell group and cell class | 3.11e-04 | 185 | 32 | 3 | 69304d7dd406ac7e96d51c239d7035a06d88704f | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.11e-04 | 185 | 32 | 3 | 27dbfcd40ec832d5cf757331d8af3b5176ae90fb | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.11e-04 | 185 | 32 | 3 | 08fad1e3c3cc5f1c3eb6629a49c094b628e75a92 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.11e-04 | 185 | 32 | 3 | 1c23891e4d75f99296d1304af7a9d6c3cb28d04c | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.11e-04 | 185 | 32 | 3 | ca8e921a6b45cd39474b9f86c95e7be023585c5d | |
| ToppCell | Control-Endothelial-Endothelial-Artery|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.16e-04 | 186 | 32 | 3 | 2d3a975d2bf92e18e3410dd413fc9f84831d82de | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.26e-04 | 188 | 32 | 3 | 6ee3f8f94ea7bdf652c9575fc65bff08070093a4 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.26e-04 | 188 | 32 | 3 | c29aaae3c5bb7cd6b9b3defd4d27afde3af19ba0 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.26e-04 | 188 | 32 | 3 | 0501a8aa850bd2e347020abd1cac4d8075738189 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Artery|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.31e-04 | 189 | 32 | 3 | b028466fcd36fdeceec752e55a24286a1cd62ae4 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Artery|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.36e-04 | 190 | 32 | 3 | aed65d584ca0c25f6a8313c66b421a6618af82ea | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Artery|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.41e-04 | 191 | 32 | 3 | 4b3d5157344dbfbf4fab518611cd9fa37fac7bd9 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.41e-04 | 191 | 32 | 3 | 7b386512284dfaa0e95358b28ee82632ee965e64 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-B_(Artery)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.57e-04 | 194 | 32 | 3 | 582db7f7fa9aa08027ae18ed607945b5d1dc908a | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.57e-04 | 194 | 32 | 3 | 43eb677a76634bb9a48a40e0d607c4936ae64bcc | |
| ToppCell | 343B-Endothelial_cells-Endothelial-B_(Artery)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.57e-04 | 194 | 32 | 3 | bda89111386398a072b70e8153b2a762298a047a | |
| ToppCell | cellseq2-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-AEC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.62e-04 | 195 | 32 | 3 | 75db19c0371320ea5fce1d6de8c1b40b1e6a2e58 | |
| ToppCell | (6)_Endothelial_cells-(6)_Endothelial-B_(Artery)|(6)_Endothelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.68e-04 | 196 | 32 | 3 | f540cf17b4405a6dd38d2b6123e6541d0aac889e | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.79e-04 | 198 | 32 | 3 | 1b90d632e59c3c47b936e829cceeb0334f05f34f | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.79e-04 | 198 | 32 | 3 | 524305c5d7b1d53e86ec0af775efefa3e0955e47 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.79e-04 | 198 | 32 | 3 | fc00cb25cdc6c31b7f9d397bc9f9a8f4e9708003 | |
| ToppCell | Tracheal-10x5prime-Endothelial-Endothelia_vascular-VE_pulmonary_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.85e-04 | 199 | 32 | 3 | 9735a1dc10910f02f1106b20ae5ab4c09c21305e | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.85e-04 | 199 | 32 | 3 | edd5300da1a3b758210ff8f949e9d1988b8bc7e2 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-ADAMTSL1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.90e-04 | 200 | 32 | 3 | e1fca7ee2dc18c7fded53c3561f519c1fcd9767a | |
| ToppCell | COVID-19-COVID-19_Convalescent-Lymphocyte-T/NK-CD8+_T_naive|COVID-19_Convalescent / Disease, condition lineage and cell class | 3.90e-04 | 200 | 32 | 3 | 65ae349fac4084faacbc6a645a92398f6324770e | |
| ToppCell | Neuronal-Excitatory-eE(FEZF2_SLC17A7)-eE_2-OR2T8--L6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.90e-04 | 200 | 32 | 3 | 70ab4d65d1a6b93459d44bdfe974d3ad90d0ab83 | |
| ToppCell | Neuronal-Excitatory-eE(FEZF2_SLC17A7)-eE_2-OR2T8|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.90e-04 | 200 | 32 | 3 | 5fa4d589f5c5f7891dccfc877d6d0929d5e85436 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-ADAMTSL1-L1-3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.90e-04 | 200 | 32 | 3 | 4409471479dd7c0f770bcb84ba7b3652c4706743 | |
| ToppCell | Neuronal-Excitatory-eE(FEZF2_SLC17A7)-eE_2-OR2T8-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.90e-04 | 200 | 32 | 3 | 6e428c0bff8c8feffaae6ff21dcfd22476ad7082 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.90e-04 | 200 | 32 | 3 | 75649534a98bc738fca62d071de0978dc61eb24f | |
| Disease | breast cancer (is_marker_for) | 9.58e-04 | 185 | 31 | 3 | DOID:1612 (is_marker_for) | |
| Disease | melanoma | 2.22e-03 | 248 | 31 | 3 | C0025202 | |
| Disease | ovarian cancer (is_marker_for) | 2.33e-03 | 68 | 31 | 2 | DOID:2394 (is_marker_for) | |
| Disease | Cleft palate | 2.54e-03 | 71 | 31 | 2 | HP_0000175 | |
| Disease | esophagus squamous cell carcinoma (is_marker_for) | 2.75e-03 | 74 | 31 | 2 | DOID:3748 (is_marker_for) | |
| Disease | stem Cell Growth Factor beta measurement | 2.83e-03 | 75 | 31 | 2 | EFO_0008292 | |
| Disease | Lung diseases | 3.05e-03 | 78 | 31 | 2 | C0024115 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DIDCPGLEKCCPWSG | 136 | Q5DID0 | |
| KDDGCCLWHLKPPSC | 876 | Q96QE3 | |
| WLKPCCGVFPFCLCD | 561 | P54793 | |
| CNPVLCPWGKKAFSG | 176 | P10768 | |
| WLGLNPLKAFCVCCK | 606 | Q9Y4B4 | |
| PLKAFCVCCKIWNHP | 611 | Q9Y4B4 | |
| LDWSECTPKCGPGFK | 966 | Q9UKP5 | |
| KLCAGLDCPWKFCDE | 3736 | Q14517 | |
| QRCFEKCPWEKCPAP | 41 | Q5T871 | |
| CIPGCTKNPCWFLKN | 436 | Q5T1H1 | |
| DFGKKDCPWPCPKCR | 206 | Q6ZNB6 | |
| LKVFPDPWACPLKCC | 416 | Q38SD2 | |
| DPWACPLKCCKASRN | 421 | Q38SD2 | |
| WDEDAPGCKPCHVKC | 1461 | Q92824 | |
| LTESYCGPCPKNWIC | 91 | P26718 | |
| PKGDWRCPKCVAEEC | 331 | P29375 | |
| PKACLKPCWDCGSFL | 296 | O43316 | |
| CCQLKFWLPIGCAAF | 136 | Q9Y6W8 | |
| WTKWLQKLCCPCCFG | 166 | Q9BTU6 | |
| LPGKCCEEWVCDEPK | 156 | P29279 | |
| SGICKKEPWEPQCFC | 471 | Q5VVW2 | |
| LCQCKVYWSGPCAPS | 316 | O14896 | |
| FLKGCKWAPDGSCIL | 171 | Q9BUR4 | |
| KGCIKCEAPCPEDWL | 91 | P0C7M8 | |
| GWFPRKCVEKCPCDA | 386 | Q9H6R6 | |
| WLEKNSKSCPCCGTP | 396 | Q9UBS8 | |
| GPSKEASLWPCEKCG | 901 | Q9ULJ3 | |
| GDGPFACPLCWKVFK | 346 | P0CJ78 | |
| FCCGGKLKNWEPCDR | 201 | P98170 | |
| ICCCCRAKFPLFSWP | 571 | Q8WWL2 | |
| KFFAPWCGHCKALAP | 211 | Q8NBS9 | |
| CFPCCSVDKRKPPWV | 1026 | Q9UI33 | |
| WPCLLSKACVDPACK | 1866 | Q9Y4A5 | |
| KCELCGKAFFWPSLL | 246 | P15621 |